147 related articles for article (PubMed ID: 21174222)
21. Drug-resistant tuberculosis: an experience from Qatar.
Ali M; Howady F; Munir W; Karim H; Al-Suwaidi Z; Al-Maslamani M; Alkhal A; Elmaki N; Ziglam H
Libyan J Med; 2020 Dec; 15(1):1744351. PubMed ID: 32238120
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China.
Hu Y; Mathema B; Wang W; Hoffner S; Kreiswirth B; Xu B
Microb Drug Resist; 2008 Sep; 14(3):227-32. PubMed ID: 18707239
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
[TBL] [Abstract][Full Text] [Related]
24. [Update on multidrug resistant tuberculosis in Switzerland].
Knuchel J; Lador F; Soccal PM; Janssens JP
Rev Med Suisse; 2016 Nov; 12(539):1948-1954. PubMed ID: 28696636
[TBL] [Abstract][Full Text] [Related]
25. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
26. Transmission of multidrug-resistant tuberculosis in Shanghai: roles of residential status.
Ge E; Li D; Luo M; Tsui KWS; Waye MMY; Shen X; Wei X
Int J Tuberc Lung Dis; 2018 Dec; 22(12):1462-1468. PubMed ID: 30606318
[TBL] [Abstract][Full Text] [Related]
27. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
28. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
29. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
Al-Mutairi NM; Ahmad S; Mokaddas E
Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
[TBL] [Abstract][Full Text] [Related]
30. Nationwide survey of anti-tuberculosis drug resistance in Japan.
Tuberculosis Research Committee (RYOKEN), Tokyo, Japan
Int J Tuberc Lung Dis; 2015 Feb; 19(2):157-62. PubMed ID: 25574913
[TBL] [Abstract][Full Text] [Related]
31. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
[TBL] [Abstract][Full Text] [Related]
32. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.
Kamolwat P; Nateniyom S; Chaiprasert A; Disratthakit A; Mahasirimongkol S; Yamada N; Smithtikarn S
Trop Med Int Health; 2021 Jan; 26(1):45-53. PubMed ID: 32997863
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
35. Changing patterns and trends of multidrug-resistant tuberculosis at referral centre in Northern India: a 4-year experience.
Maurya AK; Singh AK; Kumar M; Umrao J; Kant S; Nag VL; Kushwaha RA; Dhole TN
Indian J Med Microbiol; 2013; 31(1):40-6. PubMed ID: 23508428
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of tuberculosis drug resistance in 10 provinces of China.
He GX; Zhao YL; Jiang GL; Liu YH; Xia H; Wang SF; Wang LX; Borgdorff MW; van der Werf MJ; van den Hof S
BMC Infect Dis; 2008 Dec; 8():166. PubMed ID: 19077223
[TBL] [Abstract][Full Text] [Related]
37. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.
Chum HJ; O'Brien RJ; Chonde TM; Graf P; Rieder HL
AIDS; 1996 Mar; 10(3):299-309. PubMed ID: 8882670
[TBL] [Abstract][Full Text] [Related]
38. Risk factors associated with kanamycin-resistant tuberculosis in a Beijing tuberculosis referral hospital.
Yu HT; Wang Q; Yang N; Li HM; Liang JQ; Liu CH
J Med Microbiol; 2012 Jul; 61(Pt 7):960-967. PubMed ID: 22422574
[TBL] [Abstract][Full Text] [Related]
39. Integration of Mycobacterium tuberculosis drug susceptibility testing and genotyping with epidemiological data analysis to gain insight into the epidemiology of drug-resistant tuberculosis in Malatya, Turkey.
Agarwal M; Gunal S; Durmaz R; Yang Z
J Clin Microbiol; 2010 Sep; 48(9):3301-5. PubMed ID: 20660214
[TBL] [Abstract][Full Text] [Related]
40. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.
Ulmasova DJ; Uzakova G; Tillyashayhov MN; Turaev L; van Gemert W; Hoffmann H; Zignol M; Kremer K; Gombogaram T; Gadoev J; du Cros P; Muslimova N; Jalolov A; Dadu A; de Colombani P; Telnov O; Slizkiy A; Kholikulov B; Dara M; Falzon D
Euro Surveill; 2013 Oct; 18(42):. PubMed ID: 24176581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
